Danaher (DHR)
(Delayed Data from NYSE)
$245.80 USD
-4.61 (-1.84%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $245.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Total sales: Biotechnology
- 7,172.00
- 8,758.00
- 8,570.00
- 5,276.00
- --
- Revenue - Line of Business (LOBR)
- Total sales: Life Sciences
- 7,141.00
- 7,036.00
- 14,958.00
- 10,576.00
- 6,951.10
- Revenue - Line of Business (LOBR)
- Total sales: Diagnostics
- 9,577.00
- 10,849.00
- 9,844.00
- 7,403.00
- 6,561.50
- Income - Line of Business (LOBI)
- Operating profit: Biotechnology
- 1,909.00
- 3,008.00
- 3,074.00
- --
- --
- Income - Line of Business (LOBI)
- Operating profit: Life Sciences
- 1,209.00
- 1,414.00
- 4,367.00
- 2,054.00
- 1,401.00
- Income - Line of Business (LOBI)
- Operating profit: Diagnostics
- 2,406.00
- 3,436.00
- 2,313.00
- 1,538.00
- 1,134.00
- Income - Line of Business (LOBI)
- Operating profit: Other
- -322.00
- -305.00
- -269.00
- -340.00
- -318.00
- Non Financial / Operating Metric (NFM)
- Total Growth - Organic sales (Core)
- -0.50
- 8.00
- 23.00
- 9.50
- 6.00